FIELD-READY, POINT-OF-NEED INFECTION TREATMENT
Driven by Innovation. Engineered for Care.
Field-Ready Kit for Drug-Resistant Infection Control offer a portable, pre-formulated solution designed for rapid, on-the-spot deployment in military and emergency settings. These advanced kit deliver targeted topical antimicrobial therapy to control infection early, accelerate healing, and reduce medical burden ensuring personnel remain mission-capable even in high-risk environments.
UNMET NEED IN COMBAT AND CRISIS CARE
Warfighters and first responders operating in high-risk environments face a serious threat from drug-resistant wound infections. These infections can evolve rapidly, potentially resulting in sepsis, extended recovery periods, compromised operational readiness, or even mortality. Frequently associated with aggressive Gram-positive pathogens, these infections necessitate immediate and effective intervention in the field.
UNIQUE SOLUTION FOR DRUG-RESISTANT INFECTION
InnoStudio Inc., in partnership with ThalesNano Inc., has developed an innovative topical formulation of a clinically validated antibiotic that has demonstrated over 30 years of effectiveness without evidence of resistance. The antibiotic is highly effective against drug-resistant, hard-to-treat Gram positive infections, such as necrotizing fasciitis (flesh-eating bacterial infection), a life-threatening condition. The formulation is built on a novel technology platform that enables on-site, on demand production, making it a critical tool in the global fight against antimicrobial resistance.
The limited global exposure of the formulated antibiotic has preserved its potency, making it highly effective against multidrug-resistant pathogens, such as
InnoStudio Inc., in partnership with ThalesNano Inc., has developed an innovative topical formulation of a clinically validated antibiotic that has demonstrated over 30 years of effectiveness without evidence of resistance. The antibiotic is highly effective against drug-resistant, hard-to-treat Gram positive infections, such as necrotizing fasciitis (flesh-eating bacterial infection), a life-threatening condition. The formulation is built on a novel technology platform that enables on-site, on demand production, making it a critical tool in the global fight against antimicrobial resistance.
The limited global exposure of the formulated antibiotic has preserved its potency, making it highly effective against multidrug-resistant pathogens, such as
- Methicillin-resistant Staphylococcus aureus (MRSA)
- Mupirocin-resistant Staphylococcus aureus
- Vancomycin-intermediate Staphylococcus aureus (VISA)
- Vancomycin-resistant Enterococcus species (VRE)
- Pathogens associated with necrotizing soft tissue and infections (commonly referred to as flesh-eating bacteria)
Its exceptional resistance profile offers a critical advantage in managing severe infections in hospitals, emergency, and crisis zones.
OPERATIONAL SUPERIORITY – TACTICAL READINESS
Field-Ready Infection Defense
Effective against drug-resistant Gram-positive pathogens, including flesh-eating bacteria
Suppresses secondary fungal infections (e.g., Candida albicans)
Optimized for field use in expeditionary and special operations medicine
Antimicrobial Defense Redefined
Compact, pocket-sized kit for rapid use in remote environments
Two delivery formats:
- Tactical sachets for emergency field application
- Dual-syringe applicators for precision delivery
Critical Care at the Point of Need
Designed for complex trauma and high-risk wounds, including burns and blast injuries.
Effective for severe infections like soft tissue necrosis and diabetic ulcers.
Integrates with systemic antibiotics and antifungals.
Improves recovery and survival rates in military and civilian care.